Literature DB >> 12716795

Importance of obtaining independent measures of insulin secretion and insulin sensitivity during the same test: results with the Botnia clamp.

Devjit Tripathy1, Ylva Wessman, Monica Gullström, Tiinamaija Tuomi, Leif Groop.   

Abstract

OBJECTIVE: To validate and apply a method for independent assessment of insulin secretion and insulin sensitivity (S(I)) during the same test; that is, an intravenous glucose tolerance test followed by a euglycemic-hyperinsulinemic clamp, also called the Botnia clamp. This test was then applied to nondiabetic subjects with (FH+) and without (FH-) a first-degree family history of diabetes. RESEARCH DESIGN AND METHODS: The Botnia clamp measures the first-phase insulin response (FPIR) to 0.3g/kg glucose i.v. and insulin sensitivity (M-value) from a 2-h euglycemic clamp begun 60 min after the glucose bolus. The M-value obtained during the Botnia clamp was compared with M-values obtained during a regular euglycemic clamp without prior glucose bolus. Repeated tests were performed in random order in subjects with normal and abnormal glucose tolerance. Finally, the test was applied to subjects with and without a family history of type 2 diabetes.
RESULTS: S(I) and insulin secretion from this test showed a high degree of reproducibility, and the M-value obtained with the Botnia clamp correlated strongly with the M-value from a euglycemic clamp without prior glucose bolus (r = 0.953, P < 0.005). FH+ subjects showed decreased S(I) (P = 0.02), but similar FPIR, compared with FH- subjects. However, insulin secretion adjusted for the degree of insulin resistance was significantly impaired (P = 0.04).
CONCLUSIONS: In conclusion, the Botnia clamp provides reliable and independent measures of S(I) and beta-cell function during the same test. As illustrated above, knowledge of the degree of S(I) is mandatory when presenting data on insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716795     DOI: 10.2337/diacare.26.5.1395

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  25 in total

1.  The Association of Polyunsaturated Fatty Acid δ-5-Desaturase Activity with Risk Factors for Type 2 Diabetes Is Dependent on Plasma ApoB-Lipoproteins in Overweight and Obese Adults.

Authors:  Valérie Lamantia; Simon Bissonnette; Viviane Provost; Marie Devaux; Yannick Cyr; Caroline Daneault; Christine Des Rosiers; May Faraj
Journal:  J Nutr       Date:  2019-01-01       Impact factor: 4.798

2.  Estimates of insulin sensitivity from the intravenous-glucose-modified-clamp test depend on suppression of lipolysis in type 2 diabetes: a randomised controlled trial.

Authors:  Sabine Kahl; Bettina Nowotny; Simon Piepel; Peter J Nowotny; Klaus Strassburger; Christian Herder; Giovanni Pacini; Michael Roden
Journal:  Diabetologia       Date:  2014-07-22       Impact factor: 10.122

3.  Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects.

Authors:  M Walker; A Mari; M K Jayapaul; S M A Bennett; E Ferrannini
Journal:  Diabetologia       Date:  2005-11-01       Impact factor: 10.122

4.  The CREBRF diabetes-protective rs373863828-A allele is associated with enhanced early insulin release in men of Māori and Pacific ancestry.

Authors:  Hannah J Burden; Shannon Adams; Braydon Kulatea; Morag Wright-McNaughton; Danielle Sword; Jennifer J Ormsbee; Conor Watene-O'Sullivan; Tony R Merriman; Jennifer L Knopp; J Geoffrey Chase; Jeremy D Krebs; Rosemary M Hall; Lindsay D Plank; Rinki Murphy; Peter R Shepherd; Troy L Merry
Journal:  Diabetologia       Date:  2021-08-21       Impact factor: 10.122

Review 5.  Assessment of insulin action on carbohydrate metabolism: physiological and non-physiological methods.

Authors:  S Dube; I Errazuriz; C Cobelli; R Basu; A Basu
Journal:  Diabet Med       Date:  2013-06       Impact factor: 4.359

6.  A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion.

Authors:  S A Schäfer; K Müssig; H Staiger; F Machicao; N Stefan; B Gallwitz; H U Häring; A Fritsche
Journal:  Diabetologia       Date:  2009-03-28       Impact factor: 10.122

7.  Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study.

Authors:  M Laakso; J Zilinskaite; T Hansen; T Welløv Boesgaard; M Vänttinen; A Stancáková; P-A Jansson; F Pellmé; J J Holst; T Kuulasmaa; M L Hribal; G Sesti; N Stefan; A Fritsche; H Häring; O Pedersen; U Smith
Journal:  Diabetologia       Date:  2007-12-14       Impact factor: 10.122

8.  Precision and accuracy of hyperglycemic clamps in a multicenter study.

Authors:  Kieren J Mather; Ashley H Tjaden; Adam Hoehn; Kristen J Nadeau; Thomas A Buchanan; Steven E Kahn; Silva A Arslanian; Sonia Caprio; Karen M Atkinson; Melanie Cree-Green; Kristina M Utzschneider; Sharon L Edelstein
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-03-01       Impact factor: 4.310

9.  Polymorphism rs11085226 in the gene encoding polypyrimidine tract-binding protein 1 negatively affects glucose-stimulated insulin secretion.

Authors:  Martin Heni; Caroline Ketterer; Robert Wagner; Katarzyna Linder; Anja Böhm; Silke A Herzberg-Schäfer; Fausto Machicao; Klaus-Peter Knoch; Andreas Fritsche; Harald Staiger; Hans-Ulrich Häring; Michele Solimena
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

10.  Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived 'browning' factor irisin, determines insulin sensitivity.

Authors:  Harald Staiger; Anja Böhm; Mika Scheler; Lucia Berti; Jürgen Machann; Fritz Schick; Fausto Machicao; Andreas Fritsche; Norbert Stefan; Cora Weigert; Anna Krook; Hans-Ulrich Häring; Martin Hrabě de Angelis
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.